Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study

Name: Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

locally advanced undifferentiated pleomorphic sarcoma, metastatic undifferentiated pleomorphic sarcoma, recurrent undifferentiated pleomorphic sarcoma, unresectable undifferentiated pleomorphic sarcoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230407
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.